BR100 Increased By (0.99%)
BR30 Increased By (0.38%)
KSE100 Increased By (1.06%)
KSE30 Increased By (1.14%)
BECO 5.39 Increased By ▲ 0.07 (1.32%)
BML 56.48 Increased By ▲ 1.39 (2.52%)
BOP 35.09 Increased By ▲ 0.05 (0.14%)
CNERGY 8.17 Increased By ▲ 0.08 (0.99%)
DCL 11.44 Increased By ▲ 0.08 (0.7%)
FCCL 57.55 Increased By ▲ 1.36 (2.42%)
FCSC 5.00 Decreased By ▼ -0.01 (-0.2%)
FFL 17.88 Increased By ▲ 0.20 (1.13%)
FNEL 1.25 Increased By ▲ 0.01 (0.81%)
HUMNL 11.17 Increased By ▲ 0.24 (2.2%)
KEL 8.54 Decreased By ▼ -0.03 (-0.35%)
KOSM 6.73 Increased By ▲ 0.24 (3.7%)
MLCF 106.91 Increased By ▲ 0.40 (0.38%)
NBP 198.50 Decreased By ▼ -1.26 (-0.63%)
PACE 11.07 Increased By ▲ 0.05 (0.45%)
PAEL 45.45 Increased By ▲ 0.45 (1%)
PIAHCLA 31.43 Increased By ▲ 2.86 (10.01%)
PIBTL 19.08 Increased By ▲ 0.81 (4.43%)
PPL 242.62 Decreased By ▼ -1.87 (-0.76%)
PRL 35.67 Increased By ▲ 0.73 (2.09%)
PTC 65.52 Decreased By ▼ -0.30 (-0.46%)
SEARL 94.54 Increased By ▲ 0.49 (0.52%)
SSGC 32.08 Increased By ▲ 1.25 (4.05%)
TELE 8.87 Increased By ▲ 0.17 (1.95%)
THCCL 65.66 Increased By ▲ 0.67 (1.03%)
TPLP 10.73 Increased By ▲ 0.47 (4.58%)
TREET 25.11 Increased By ▲ 0.24 (0.97%)
TRG 63.67 Increased By ▲ 0.31 (0.49%)
WAVES 10.70 Increased By ▲ 0.05 (0.47%)
WTL 1.25 Increased By ▲ 0.01 (0.81%)
Business & Finance

WTI Falls Below $39 as COVID fears sweep through

  • West Texas Intermediate drops to below $39 amid COVID-19 fears and rise in oil production.
Published October 27, 2020 Updated October 27, 2020 02:06pm
Source: ActivTrades
Source: ActivTrades

West Texas Intermediate drops to below $39 and steadies with COVID-19 wave fears sweep through.

Global oil prices have fallen sharply as a ceasefire between warring factions in Libya meant that production is now forecast to rise even as governments implement more stringent restrictions to cope with a surge in coronavirus cases.

West Texas Intermediate Crude oil futures for December ended down $1.29 or about 3.2% at $38.56 a barrel, the lowest close since October 2.

With the US elections approaching on the 2rd of November and coronavirus fears resurfacing dramatically, energy and healthcare stocks were among the worst hit.

Despite the recent FDA approval for remdesivir and the prospects of the Johnson Johnson trials, the second wave has impacted the demand-side risk in the energy markets. Cases are also increasing to record numbers in Europe, forcing the countries to revert back to even more social distancing to avoid full-scale lockdowns.

New restrictions have been announced in Spain and Italy to control the surge of infections, which are expected to grow even further in the upcoming winters. In the US several advisors and aides within the Vice President’s inner circle have been tested positive.

Comments

Comments are closed for this article.